Bulletin 2012/02 - European Patent Office
31.12.2012 • Views
Share Embed Flag

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) II.1(1)<br />

(21) 08153545.2 (22) 28.03.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(43) 01.10.2008<br />

(30) 28.03.2007 US 907317 P<br />

28.03.2007 EP 07105094<br />

(54) • Verwendung einer hilfsstoffhaltigen Impfstoffformulierung<br />

für parenterale Verabreichung<br />

• Use of an adjuvanted allergy vaccine<br />

formulation for parenteral administration<br />

• Utilisation de formule adjuvante de vaccin<br />

contre les allergies pour administration<br />

parentérale<br />

(73) Alk-Abelló A/S, Bøge Allé 6-8, 2970<br />

Hørsholm, DK<br />

(72) Wüstenberg, Eike Gunther, 22589 Hamburg,<br />

DE<br />

(74) Inspicos A/S, Kogle Allé 2 P.O. Box 45, 2970<br />

Hørsholm, DK<br />

A61K 39/00 → (51) A61K 39/395<br />

A61K 39/00 → (51) A61K 39/40<br />

A61K 39/00 → (51) C12Q 1/68<br />

A61K 39/0<strong>02</strong> → (51) C12N 1/10<br />

(51) A61K 39/08 (11) 2 086 578 B1<br />

(25) En (26) En<br />

(21) 07822693.3 (22) 19.11.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(43) 12.08.2009<br />

(86) EP 2007/062484 19.11.2007<br />

(87) WO 2008/061950 2008/22 29.05.2008<br />

(30) 20.11.2006 EP 06124404<br />

20.11.2006 US 860447 P<br />

(54) • VERWENDUNG VON CLOSTRIDIUM<br />

PERFRINGENS-TYP C-BAKTERIUM ZUR<br />

HERSTELLUNG EINES IMPFSTOFFS<br />

• USE OF CLOSTRIDIUM PERFRINGENS<br />

TYPE C BACTERIUM FOR THE MANUFAC-<br />

TURE OF A VACCINE<br />

• UTILISATION D'UNE BACTÉRIE DE CLOS-<br />

TRIDIUM PERFRINGENS TYPE C POUR LA<br />

FABRICATION D'UN VACCIN<br />

(73) Intervet International B.V., P.O. Box 31 Wim<br />

De Körverstraat 35, 5831 AN Boxmeer, NL<br />

(72) WITVLIET, Maarten Hendrik, 5831 AN<br />

Boxmeer, NL<br />

SMEETS, Jozef Franciscus Maria, 5831 AN<br />

Boxmeer, NL<br />

REDHEAD, Keith, Milton, Keynes MK7 7AJ,<br />

GB<br />

(74) Janssen, Paulus J. P., et al, Merck Sharp &<br />

Dohme Ltd. Hertford Road Hoddesdon,<br />

Hertfordshire, EN11 9BU, NL<br />

A61K 39/08 → (51) A61K 38/16<br />

A61K 39/12 → (51) A61K 39/40<br />

A61K 39/21 → (51) A61K 39/40<br />

(51) A61K 39/245 (11) 1 248 648 B1<br />

A61K 39/39 A61K 39/295<br />

A61P 31/22 A61K 39/295<br />

A61K 39/245 A61K 39/23<br />

A61K 39/295 A61K 39/245<br />

A61K 39/235 A61K 39/295<br />

A61K 39/245 A61K 39/175<br />

(25) Fr (26) Fr<br />

(21) 01905858.5 (22) 19.01.2001<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 16.10.20<strong>02</strong><br />

(86) FR 2001/000189 19.01.2001<br />

(87) WO 2001/052887 2001/30 26.07.2001<br />

(30) 21.01.2000 FR 0000797<br />

(54) • IMPFUNG UND IMPFSTOFFE GEGEN<br />

HUNDEHERPESVIRUS<br />

• VACCINATION AGAINST CANINE HER-<br />

PESVIRUS INFECTION AND VACCINES<br />

• VACCINATION CONTRE L'HERPESVIROSE<br />

CANINE ET VACCINS<br />

(73) MERIAL, 29, Avenue Tony Garnier, 69007<br />

Lyon, FR<br />

(72) POULET, Hervé, F-69110 Sainte Foy les<br />

Lyon, FR<br />

(74) Nargolwalla, Cyra, et al, Cabinet Plasseraud<br />

52, rue de la Victoire, 75440 Paris Cedex 09,<br />

FR<br />

A61K 39/295 → (51) A61K 39/245<br />

A61K 39/295 → (51) A61K 39/40<br />

A61K 39/38 → (51) A61K 39/40<br />

A61K 39/385 → (51) A61K 39/40<br />

A61K 39/39 → (51) A61K 39/245<br />

A61K 39/39 → (51) C12N 15/117<br />

(51) A61K 39/395 (11) 1 370 288 B1<br />

A61P 7/00 C07K 16/28<br />

(25) En (26) En<br />

(21) 01996390.9 (22) 20.11.2001<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 17.12.2003<br />

(86) CA 2001/001648 20.11.2001<br />

(87) WO 20<strong>02</strong>/040047 20<strong>02</strong>/21 23.05.20<strong>02</strong><br />

(30) 20.11.2000 US 249441 P<br />

(54) • VERFAHREN ZUR BEHANDLUNG DER<br />

THROMBOZYTOPENIE MIT MONOKLONA-<br />

LEM IVIG<br />

• METHOD FOR TREATING THROMBOCY-<br />

TOPENIA WITH MONOCLONAL IVIG<br />

• PROCEDE SERVANT A TRAITER LA<br />

THROMBOCYTOPENIE AU MOYEN D'IM-<br />

MUNOGLOBULINE INTRAVEINEUSE<br />

MONOCLONALE<br />

(73) Canadian Blood Services, 1800 Alta Vista<br />

Drive, Ottawa, Ontario K1G 4J5, CA<br />

(72) LAZARUS, Alan, H., Toronto, Ontario M4H<br />

1J6, CA<br />

FREEDMAN, John, Toronto, Ontario M4Y<br />

1R8, CA<br />

SONG, Seng, Toronto, Ontario M4C 4Y2, CA<br />

CROW, Andrew, R., Toronto, Ontario M4C<br />

5L4, CA<br />

(74) Williams, Aylsa, D Young & Co LLP 120<br />

Holborn, London EC1N 2DY, GB<br />

(60) 10178480.9 / 2 283 861<br />

(51) A61K 39/395 (11) 1 401 497 B1<br />

A61K 39/00<br />

(25) En (26) En<br />

(21) <strong>02</strong>749560.5 (22) 10.06.20<strong>02</strong><br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 31.03.2004<br />

(86) US 20<strong>02</strong>/017881 10.06.20<strong>02</strong><br />

(87) WO 20<strong>02</strong>/100432 20<strong>02</strong>/51 19.12.20<strong>02</strong><br />

(30) 08.06.2001 US 297190 P<br />

(54) • VERFAHREN ZUR MODULATION VON IL-<br />

13<br />

• METHODS FOR THE MODULATION OF IL-<br />

13<br />

523<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>02</strong>/<strong>2012</strong>) 11.01.<strong>2012</strong><br />

• PROCEDES RELATIFS A LA MODULATION<br />

DE L'IL-13<br />

(73) GENAERA CORPORATION, 5110 Campus<br />

Drive, Plymouth Meeting, PA 19462, US<br />

(72) ZHOU, Yuhong, Genaera Corp., Plymouth<br />

Meeting, PA 19462, US<br />

LOUAHED, Jamila, Genaera Corp., Plymouth<br />

Meeting, PA 19462, US<br />

NICOLAIDES, Nicholas, Genaera Corp., Plymouth<br />

Meeting, PA 19462, US<br />

MCLANE, Michael, Genaera Corp., Pymouth<br />

Meeting, PA 19462, US<br />

LEVITT, Roy C., Genaera Corporation, Plymouth<br />

Meeting, PA 19462, US<br />

(74) Swinkels, Bart Willem, et al, Nederlandsch<br />

Octrooibureau P.O. Box 29720, 25<strong>02</strong> LS Den<br />

Haag, NL<br />

(51) A61K 39/395 (11) 1 737 489 B1<br />

(25) En (26) En<br />

(21) 05734984.7 (22) 07.04.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

(43) 03.01.2007<br />

(86) US 2005/011781 07.04.2005<br />

(87) WO 2005/099756 2005/43 27.10.2005<br />

(30) 08.04.2004 US 561076 P<br />

(54) • ErbB2-Antagonisten für die Tumorschmerztherapie<br />

• ErbB2 antagonists for tumor pain therapy<br />

• Antagonistes d' ErbB2 pour le traitement<br />

de la douleur tumorale<br />

(73) Agus, David B, 1117 North Beverly Drive,<br />

Beverly Hills, CA 9<strong>02</strong>10, US<br />

(72) Agus, David B, Beverly Hills, CA 9<strong>02</strong>10, US<br />

(74) Walton, Seán Malcolm, et al, Mewburn Ellis<br />

LLP 33 Gutter Lane, London EC2V 8AS, GB<br />

A61K 39/395 → (51) A61K 39/40<br />

A61K 39/395 → (51) C07K 16/00<br />

(51) A61K 39/40 (11) 1 572 074 B1<br />

A61K 39/395 A61K 39/38<br />

A61K 39/00 A61K 39/12<br />

A61K 39/21 A61K 39/385<br />

A61K 39/295 A61K 9/68<br />

A61K 51/00 A61M 36/14<br />

(25) En (26) En<br />

(21) 03709134.5 (22) 14.<strong>02</strong>.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT SE SI SK TR<br />

(43) 14.09.2005<br />

(86) US 2003/004711 14.<strong>02</strong>.2003<br />

(87) WO 2003/068169 2003/34 21.08.2003<br />

(30) 14.<strong>02</strong>.20<strong>02</strong> US 76674<br />

31.01.2003 US 355161<br />

(54) • STABILISIERTES SYNTHETISCHES IMMU-<br />

NOGEN-ABGABESYSTEM<br />

• STABILIZED SYNTHETIC IMMUNOGEN<br />

DELIVERY SYSTEM<br />

• SYSTEME D'ADMINISTRATION D'IMMU-<br />

NOGENE SYNTHETIQUE STABILISE<br />

(73) United Biomedical, Inc., 25 Davids Drive,<br />

Hauppauge, New York 11788, US<br />

(72) SOKOLL, Kenneth, K., Stony Brook, NY<br />

11790, US<br />

(74) Strych, Werner Maximilian Josef, Hansmann<br />

& Vogeser, <strong>Patent</strong>- und Rechtsanwälte,<br />

Albert-Rosshaupter-Strasse 65, 81369<br />

München, DE<br />

A61K 45/00 → (51) A61K 31/4412<br />

A61K 47/<strong>02</strong> → (51) B22F 9/24<br />

A61K 47/04 → (51) A61K 47/36

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!